Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000471241 | SCV000544983 | likely benign | Gorlin syndrome; Medulloblastoma | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000562404 | SCV000675284 | likely benign | Hereditary cancer-predisposing syndrome | 2023-02-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000726658 | SCV000702010 | uncertain significance | not provided | 2016-10-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763642 | SCV000894513 | uncertain significance | Gorlin syndrome; Medulloblastoma; Familial meningioma; Joubert syndrome 32 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726658 | SCV002756761 | uncertain significance | not provided | 2022-05-17 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Identified in healthy individuals undergoing whole genome sequencing (Bodian 2014); This variant is associated with the following publications: (PMID: 24311597, 24728327) |
Baylor Genetics | RCV003460861 | SCV004205674 | uncertain significance | Familial meningioma | 2024-03-15 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000122098 | SCV000086313 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |